OKYO Pharma (OKYO) Current Assets (2021 - 2025)

OKYO Pharma (OKYO) has 5 years of Current Assets data on file, last reported at $4.6 million in Q3 2025.

• Current Assets for Q3 2025 came in at $4.6 million, up 64.24% year-over-year; the trailing twelve-month figure through Sep 2025 was $4.6 million (up 64.24% YoY), and the FY2025 annual result was $3.7 million, up 138.98% from the prior year.
• Current Assets improved to $4.6 million in Q3 2025 per OKYO's latest filing, from $3.7 million in the prior quarter.
• Over five years, Current Assets peaked at $7.0 million in Q1 2021 and troughed at $1.5 million in Q1 2024.
• A 5-year average of $3.9 million and a median of $4.0 million in 2022 frame the typical range for Current Assets.
• The sharpest annual moves came in 2024 and 2025: Current Assets plunged 70.41% in 2024, then surged 138.98% in 2025.
• A 5-year view of Current Assets shows it stood at $7.0 million in 2021, then slumped by 38.52% to $4.3 million in 2022, then slumped by 44.78% to $2.4 million in 2023, then grew by 19.17% to $2.8 million in 2024, then surged by 64.24% to $4.6 million in 2025.
• Business Quant data shows OKYO's Current Assets at $4.6 million in Q3 2025, $3.7 million in Q1 2025, and $2.8 million in Q3 2024.